The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.
Ma K, Hong B, Zhou J, Gong Y, Wang J, Liu S, Peng X, Zhou B, Zhang J, Xie H, Zhang K, Li L, Cai D, Wang Z, Cai L, Gong K.
Ma K, et al. Among authors: zhang j, zhang k.
Front Oncol. 2019 Nov 1;9:1122. doi: 10.3389/fonc.2019.01122. eCollection 2019.
Front Oncol. 2019.
PMID: 31737565
Free PMC article.